These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Diagnosis and treatment in systemic amyloidosis]. Ikeda S Rinsho Byori; 2008 Feb; 56(2):121-9. PubMed ID: 18404826 [TBL] [Abstract][Full Text] [Related]
4. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study. Perz JB; Schonland SO; Hundemer M; Kristen AV; Dengler TJ; Zeier M; Linke RP; Ho AD; Goldschmidt H Br J Haematol; 2004 Dec; 127(5):543-51. PubMed ID: 15566357 [TBL] [Abstract][Full Text] [Related]
5. High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. Lachmann HJ; Wechalekar AD; Gillmore JD N Engl J Med; 2008 Jan; 358(1):91-2; author reply 92-3. PubMed ID: 18175386 [No Abstract] [Full Text] [Related]
6. High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. Jaccard A; Moreau P; Leblond V; Leleu X; Benboubker L; Hermine O; Recher C; Asli B; Lioure B; Royer B; Jardin F; Bridoux F; Grosbois B; Jaubert J; Piette JC; Ronco P; Quet F; Cogne M; Fermand JP; N Engl J Med; 2007 Sep; 357(11):1083-93. PubMed ID: 17855669 [TBL] [Abstract][Full Text] [Related]
10. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785 [TBL] [Abstract][Full Text] [Related]
11. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature]. Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442 [TBL] [Abstract][Full Text] [Related]
18. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know]. Arbustini E; Gavazzi A; Merlini G Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807 [TBL] [Abstract][Full Text] [Related]
19. Nephrotoxic potential of Bence Jones proteins. Solomon A; Weiss DT; Kattine AA N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132 [TBL] [Abstract][Full Text] [Related]
20. [Therapy options in systemic AL-amyloidosis with renal involvement]. Hetzel GR; Schneider P; Mondry A; Heering P; Heyll A; Grabensee B Dtsch Med Wochenschr; 2000 Aug; 125(34-35):997-1002. PubMed ID: 11004911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]